GMVDF — G Medical Innovations Holdings Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$7.17m
- $5.53m
Annual cashflow statement for G Medical Innovations Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.99 | -3.02 | -27.2 | -17 | -15.5 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0 | 0.244 | 19 | -0.45 | 3.79 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.189 | 0.252 | 0.058 | -0.682 | 2.92 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -1.79 | -2.5 | -8.29 | -15.5 | -6.3 |
Capital Expenditures | -0.048 | -0.089 | -1.49 | -2.37 | -0.429 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | -0.034 | -0.011 | -2.49 | 0 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.048 | -0.123 | -1.5 | -4.86 | -0.429 |
Financing Cash Flow Items | — | — | 4.9 | 3.84 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.89 | 3.33 | 23.1 | 8.85 | 4.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.047 | 0.705 | 13.4 | -11.5 | -2.63 |